Gina K. Thomson

Gina K. Thomson

Auto-generated profile, based on publicly available information

Gina K. Thomson

University of Louisville Hospital, Louisville, KY, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2019 in Antibiotics
Verified
Journal Article
Open access
PDF file
KTKenneth Thomson
Kenneth Thomson
SASameh AbdelGhani
Sameh AbdelGhani
JSJames W. Snyder
James W. Snyder
GTGina K. Thomson
Gina K. Thomson
This study compared the activity of cefepime + zidebactam (FEP-ZID) and selected currently available antibacterial agents against a panel of multidrug-resistant (MDR) clinical isolates chosen to provide an extreme challenge for antibacterial activity. FEP–ZID had a very broad and potent in vitro spectrum of activity, and was highly active against many MDR isolates of Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii. Notably, it inhibited isolates producing carbapenemases of Ambler classes A, B, and D, and P. aeruginosa isolates with multiple resistance mechanisms including combinations of upregulated efflux, diminished or non-functional OprD porins, and AmpC overproduction. Its clinical role will be determined initially by the breakpoints assigned to it, comparison studies with other investigational β-lactamase inhibitor combinations, and ultimately by the developing body of therapeutic outcome data.

1 November 2019 in Journal of Clinical Virology
Verified
Journal Article
Closed access
CAChristopher S. Ambrose
Christopher S. Ambrose
LSLisa L. Steed
Lisa L. Steed
MBMike Brandon
Mike Brandon
KFKara Frye
Kara Frye
IOIfedapo R. Olajide
Ifedapo R. Olajide
GTGina Thomson
Gina Thomson